Molecular and Cellular Biochemistry

, Volume 311, Issue 1–2, pp 31–36

Oral administration of phytocomponent p-hydroxycinnamic acid prevents bone loss in ovariectomized rats

  • Masayoshi Yamaguchi
  • Ying Ling Lai
  • Satoshi Uchiyama
  • Taeko Nakagawa
Article

Abstract

The preventive effect of phytocomponent p-hydroxycinnamic acid (HCA) on ovariectomy (OVX)-induced bone loss was investigated. HCA (250 or 500 μg/100 g body weight) was orally administered once daily for 30 days to OVX rats. The analysis using a peripheral quantitative computed tomography (pQCT) showed that OVX caused bone loss in the femoral-metaphyseal tissues. This change was significantly restored after the administration of HCA (250 or 500 μg/100 g body weight) to OVX rats. Mineral content, mineral density, and polar strength strain index in the femoral-metaphyseal tissues were significantly decreased in OVX rats. These decreases were significantly restored after the administration of HCA (500 μg/100 g) to OVX rats. Moreover, OVX caused a significant decrease in calcium content or alkaline phosphatase activity in the femoral-diaphyseal and -metaphyseal tissues. These decreases were significantly restored after the administration of HCA (250 or 500 μg/100 g) to OVX rats. Deoxyribonucleic acid (DNA) content in the diaphyseal or metaphyseal tissues was significantly increased in OVX rats. These increases were significantly restored after oral administration of HCA (500 μg/100 g). This study demonstrates that HCA has preventive effects on OVX-induced bone loss of rats in vivo.

Keywords

p-hydroxycinnamic acid Ovariectomy Bone loss Osteoporosis Rat femur 

References

  1. 1.
    Wild RA, Buchamain JR, Myers C et al (1987) Declining adrenal androgen an association with bone loss in aging woman. Proc Soc Exp Biol Med 186:335–360Google Scholar
  2. 2.
    Cooper C, Melton J III (1995) Epidemiology of osteoporosis. Trends Endocrinol Metab 3:224–229Google Scholar
  3. 3.
    Promislow JHE, Goodman-Gruen D, Barret-Connor E et al (2002) Retinol intake and bone mineral density in the elderly: the rancho brenardo study. J Bone Miner Res 17:1349–1358PubMedCrossRefGoogle Scholar
  4. 4.
    Bonjour J-P, Schurch M-A, Rozzori R (1996) Nutritional aspects of hip fractures. Bone 18:1395–1445CrossRefGoogle Scholar
  5. 5.
    Yamaguchi M (2002) Isoflavone and bone metabolism; Its cellular mechanism and preventive role in bone loss. J Health Sci 48:209–222CrossRefGoogle Scholar
  6. 6.
    Yamaguchi M (2006) Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi 126:1117–1137PubMedCrossRefGoogle Scholar
  7. 7.
    Lai YL, Yamaguchi M (2006) Phytocomponent p-hydroxycinnamic acid stimulates bone formation and inhibits bone resorption in rat femoral tissues in vitro. Mol Cell Biochem 292:45–52PubMedCrossRefGoogle Scholar
  8. 8.
    Lai YL, Yamaguchi M (2007) Phytocomponent p-hydroxycinnamic acid inhibits osteoclast-like cell formation in mouse bone marrow cultures. Int J Mol Med 19:123–128PubMedGoogle Scholar
  9. 9.
    Lai YL, Yamaguchi M (2006) Oral administration of phytocomponent p-hydroxycinnamic acid has anabolic effects on bone calcification in femoral tissues of rats in vivo. J Health Sci 52:308–312CrossRefGoogle Scholar
  10. 10.
    Yamaguchi M, Uchiyama S, Lai YL (2007) Oral administration of phytocomponent p-hydroxycinnamic acid has a preventive effect on bone loss in streptozotocin-induced diabetic rats. Int J Mol Med 19:803–807PubMedGoogle Scholar
  11. 11.
    Uchiyama S, Yamaguchi M (2006) Oral administration of β-cryptoxanthin prevents bone loss in ovariectomized rats. Int J Mol Med 17:15–20PubMedGoogle Scholar
  12. 12.
    Yamaguchi M, Oishi H, Suketa Y (1987) Stimulatory effect of zinc on bone formation in tissue culture. Biochim Pharmacol 36:4007–4012CrossRefGoogle Scholar
  13. 13.
    Walter K, Schutt C (1965) Acid and alkaline phosphatase in serum. In: Bergmeyer HV (ed) Methods of enzymatic analysis, vol 1–2. Academic Press, New York, pp 856–860Google Scholar
  14. 14.
    Lowry OH, Rosebrough NJ, Farr AL et al (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265–275PubMedGoogle Scholar
  15. 15.
    Flanagan B, Nichols G Jr (1962) Metabolic studies of bone in vitro. IV. Collagen biosynthesis by surviving bone fragments in vitro. J Biol Chem 237:3687–3692Google Scholar
  16. 16.
    Ceriotti G (1955) Determination of nucleic acids in animal tissues. J Biol Chem 214:39–77Google Scholar
  17. 17.
    Majeska RJ, Wuthier RE (1975) Studies on matrix vesicles isolated from chick epiphyseal cartilage. Association of pyrophosphatase and ATPase activities with alkaline phosphatase. Biochem Biophys Acta 391:51–60PubMedGoogle Scholar
  18. 18.
    Canalis E, Centrella M, Buech W (1989) Insulin-like factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60–65PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC. 2007

Authors and Affiliations

  • Masayoshi Yamaguchi
    • 1
    • 2
  • Ying Ling Lai
    • 1
  • Satoshi Uchiyama
    • 1
  • Taeko Nakagawa
    • 1
  1. 1.Laboratory of Endocrinology and Molecular Metabolism, Graduate School of Nutritional SciencesUniversity of ShizuokaSuruga-kuJapan
  2. 2.Institute of Bone Health and NutrientAoi-kuJapan

Personalised recommendations